Skip to main navigation Skip to search Skip to main content

An open-label randomized trial comparing risperidone long acting injectable (RLAI) with oral antipsychotic medication in the treatment of early psychosis

    Research output: Contribution to journal › Article (Academic Journal) › peer-review

    Original languageUndefined/Unknown
    JournalEarly Intervention in Psychiatry
    Publication statusPublished - 2012

    Cite this